How GSK are revolutionizing HTE

In this case study, ACD/Labs demonstrates how GlaxoSmithKline (GSK) is revolutionizing high-throughput experimentation (HTE) by integrating automation, data analytics, and machine learning into their research workflows. The study highlights GSK's innovative use of digital tools to enhance decision-making and drive more efficient drug discovery.